Rebecka Hellsten

836 citations
23 papers · 685 · h-index 14

Impact in

  • Oncology top 10%
    • Cytokine Signaling Pathways and Interactions
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Cytokine Signaling Pathways and Interactions 9
    • Cancer Cells and Metastasis 2
    • Wnt/β-catenin signaling in development and cancer 2

Rebecka Hellsten

22 papers receiving 678 citations

Peers

Rebecka Hellsten
Comparison fields: 5 of 57
  • Oncology 314
  • Cancer Research 109
  • Pulmonary and Respiratory Medicine 183
  • Pathology and Forensic Medicine 84
  • Immunology 100
Replace Mike I. Walton with:
Mike I. Walton United Kingdom
Marilina García‐Aranda Spain
Maria Grazia Prisco Italy
Christopher J. Matheson United States
Maria Nunes Portugal
Francesco Caiazza Ireland
Hefen Sun China
Cai Bowen United States
JI Epstein United States
Wenqing Qi United States
Rebecka Hellsten relative to Mike I. Walton United Kingdom Mike I. Walton's profile →
Citations per field
00.5×1.5×2×2.3×
Mike I. Walton · 1×
Citations per year

Countries citing papers authored by Rebecka Hellsten

Since Specialization
Citations

This map shows the geographic impact of Rebecka Hellsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecka Hellsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecka Hellsten more than expected).

Fields of papers citing papers by Rebecka Hellsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecka Hellsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecka Hellsten. The network helps show where Rebecka Hellsten may publish in the future.

Co-authors

The 25 scholars most cited alongside Rebecka Hellsten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rebecka Hellsten Line = papers co-authored together Rebecka Hellsten links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201685
2 201478
3 201178
4 200768
5 201767
6 201965
7 201544
8 201628
9 201026
10 202124
11 202022
12 198321
13 200718
14 201514
15 201412
16 202010
17 20227
18 20196
19 20145
20 20223

About Rebecka Hellsten

Rebecka Hellsten is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 23 papers that have together received 685 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Prostate Cancer Treatment and Research (5 papers), Microbial Natural Products and Biosynthesis (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), NF-κB Signaling Pathways (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (314 citations), Cancer Research (109 citations), Pulmonary and Respiratory Medicine (183 citations), Pathology and Forensic Medicine (84 citations) and Immunology (100 citations). Rebecka Hellsten has collaborated with scholars based in Sweden, United States and Spain. Frequent co-authors include Anders Bjartell, Martin Johansson, Olov Sterner, Agnieszka Krzyzanowska, Anna Dahlman, Susan Evans‐Axelsson, Giacomo Canesin, Tommy Andersson, Karin Leandersson and Nishtman Dizeyi. Their work appears in journals such as The Prostate, PLoS ONE, European Urology, Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact